Filing Details

Accession Number:
0001209191-22-008025
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2022-02-09 16:24:52
Reporting Period:
2022-02-04
Accepted Time:
2022-02-09 16:24:52
Original Submission Date:
2022-02-08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1810560 Revelation Biosciences Inc. REVB () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1287235 F George Tidmarsh C/O Revelation Biosciences, Inc.
4660 La Jolla Village Dr., Suite 100
San Diego CA 92122
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-02-04 7,900 $2.31 1,481,235 No 4 P Indirect By Trust
Common Stock Acquisiton 2022-02-07 42,100 $2.61 1,523,335 No 4 P Indirect By Trust
Common Stock Acquisiton 2022-02-04 2,000 $2.45 416,156 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust
No 4 P Indirect By Trust
No 4 P Direct
Footnotes
  1. Shares are held by George Tidmarsh, Trustee George Francis Tidmarsh 2021 Irrevocable Trust with respect to which George Tidmarsh is a trustee.
  2. Represents the weighted-average price at which shares were purchased within a range between $2.50 and $2.6817. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  3. The original Form 4, filed on February 8, 2022, is being amended by this Form 4 amendment to include shares purchased directly that were inadvertently omitted in the original filing.